Senior insider sale
Chief Scientific Officer at EQUILLIUM, INC. — senior position signals high conviction
$723.8K
230.97K shares
What this filing means
CONNELLY STEPHEN plans to sell 230.97K shares of EQUILLIUM, INC. valued at approximately $723.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/5/2026ACC: 0001974158-26-000073
DirectorOfficer· Chief Scientific Officer
Since Oct 2018
230.97K
Shares to sell
$723.8K
Approx. market value
30.98K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founders shares acquired at incorporation
N/A
5/27/2017
30.98KTotal acquired30.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/27/2017 | Founders shares acquired at incorporation N/A | 30.98K | — |
| Total | 30.98K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
200K
Market value
$632.8K
6/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30.98K
Market value
$91.1K
6/5/2026
Total
Units
230.97K
Value
$723.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/4/2026 | 200K | $632.8K | — | Completed |
| Planned — Approximate Date | ||||
6/5/2026 | 30.98K | $91.1K | NASDAQ | Planned |
| Total | 230.97K | $723.8K | ||